0001127602-23-013327.txt : 20230421
0001127602-23-013327.hdr.sgml : 20230421
20230421075328
ACCESSION NUMBER: 0001127602-23-013327
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230420
FILED AS OF DATE: 20230421
DATE AS OF CHANGE: 20230421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Stan
CENTRAL INDEX KEY: 0001913199
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41455
FILM NUMBER: 23834563
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MAIA Biotechnology, Inc.
CENTRAL INDEX KEY: 0001878313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
BUSINESS PHONE: 312-416-8592
MAIL ADDRESS:
STREET 1: 444 WEST LAKE STREET, SUITE 1700
CITY: CHICAGO
STATE: IL
ZIP: 60606
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-04-20
0001878313
MAIA Biotechnology, Inc.
MAIA
0001913199
Smith Stan
444 WEST LAKE STREET, SUITE 1700
CHICAGO
IL
60606
1
1
Common Stock
2023-04-20
4
P
0
10000
3.74
A
553328
I
See Footnote
The purchases reported in this Form 4 were automatically effected pursuant to a previously executed purchasing plan of The Stan V. Smith Trust Dated 1993 that is intended to comply with Rule 10b5-1(c) promulgated under the Securities Exchange Act of 1934, as amended. These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.50 to $3.95, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, to any security holder of the Issuer, or to the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
/s/ Stan V. Smith
2023-04-21